Upcoming Podcast Spotlight: Magnitude Biosciences Takes Molecules to Market
- gracebell7
- Nov 26, 2025
- 1 min read
NETPark is excited to share that Magnitude Biosciences Ltd, one of our pioneering biotech residents, will be featured on the upcoming episode of the Molecule to Market podcast — going live Friday, 28th November.
In this episode, Dr. Fozia Saleem, CEO of Magnitude Biosciences, sits down with host Raman Sehgal to explore her remarkable career journey spanning big pharma, consumer goods, and cutting-edge biotech.
From her early days at GSK to leading a fast-growing life sciences company here at NETPark, Fozia shares insights shaped by real-world challenge and innovation — including a sink-or-swim, three-month deadline to bring an entirely new product category to market, becoming the first company to launch it in the UK.
What drives her forward?
A consistent passion for R&D, outcome-focused innovation, and game-changing technology that pushes scientific boundaries.
Listeners can expect candid reflections on leadership, vision, and seeing “the bigger picture” — or as Fozia puts it, “getting into your helicopter” to navigate complex decisions and reach the right destination.
🎙️ Listen to the podcast here:
Available from Friday, 28th November.
We’re proud to see Magnitude Biosciences continue to grow, inspire, and lead from right here at NETPark — and we can’t wait for you to tune in.
Learn more about Magnitude here
